Repeated nationwide point-prevalence surveys of antimicrobial use in Swedish hospitals: Data for actions 2003-2010

Eurosurveillance

Volumn 21, Issue 25, 2016, Pages

  Skoog, Gunilla ^a,b   Struwe, J ^a   Cars, O ^a   Hanberger, H ^c   Odenholt, I ^d   Prag, M ^e   Skarlund K ^a   Ulleryd, P ^f,g   Erntell, M ^h  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^f Department of Communicable Disease Control ^*  (Sweden)

^g UNIVERSITY OF GOTHENBURG   (Sweden)

^h Department of Communicable Disease Control   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; CEPHALOSPORIN; IMIDAZOLE; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; TERBINAFINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMMUNITY ACQUIRED INFECTION; COMMUNITY ACQUIRED PNEUMONIA; COMPARATIVE STUDY; FEMALE; HEALTH CARE PLANNING; HEALTH CARE SURVEY; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INTERVENTION STUDY; LENGTH OF STAY; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEWBORN; PRACTICE GUIDELINE; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; SCHOOL CHILD; URINARY TRACT INFECTION; VERY ELDERLY; WORLD HEALTH ORGANIZATION; YOUNG ADULT; BACTERIAL INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HOSPITALIZATION; PRESCRIPTION; PROTOCOL COMPLIANCE; STANDARDS; STATISTICS AND NUMERICAL DATA; SWEDEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG PRESCRIPTIONS; FEMALE; GUIDELINE ADHERENCE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK FACTORS; SWEDEN; YOUNG ADULT;

EID: 85015356234     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.25.30264     Document Type: Article

References (31)

1. Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis. 2008;8(2): 125-32. DOI: 10.1016/S1473-3099(08)70017-3 PMID: 18222163
2. Public Health Agency of Sweden and National Veterinary Institute. Swedres-Svarm 2014. [Consumption of antibiotics and occurrence of antibiotic resistance in Sweden.] Solna/Uppsala: 2015. Available from: http://www. folkhalsomyndigheten.se/publicerat-material/publikationer/Swedres-Svarm-2014/
3. Struwe J, Sjögren A. [Every tenth hospitalized patient is given antibiotics for a nosocomial infection]. Lakartidningen. 2002;99(32-33): 3211-3.PMID: 12219475
4. The National Board of Health and Welfare. Statistical Database, In-patient Care Diagnoses. Stockholm: Socialstyrelsen. [Accessed 25 June 2014]. Available from: http://www.socialstyrelsen.se/statistics/statisticaldatabase/inpatientcarediagnoses
5. Swedish Strategic Programme Against Antibiotic Resistance (Strama). Survey protocol in nationwide hospital pointprevalence surveys in Sweden, 2003-2010. [Accessed 22 June 2016]. Available from: http://strama.se/examples-of-projects/?lang=en
6. World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index. Oslo: Norwegian Institute of Public Health. Updated 19 Dec 2013. Available from: http://www.whocc.no/atc_ddd_index/
7. Ansari F, Erntell M, Goossens H, Davey P. The European surveillance of antimicrobial consumption (ESAC) pointprevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis. 2009;49(10): 1496-504. DOI: 10.1086/644617 PMID: 19842976
8. Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, et al., ESAC-3 Hospital Care Subproject Group. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chemother. 2011;66(2): 443-9. DOI: 10.1093/jac/dkq430 PMID: 21084362
9. Vlahović-Palcevski V, Dumpis U, Mitt P, Gulbinovic J, Struwe J, Palcevski G, et al. Benchmarking antimicrobial drug use at university hospitals in five European countries. Clin Microbiol Infect. 2007;13(3): 277-83. DOI: 10.1111/j.1469-0691.2006.01613.x PMID: 17391382
10. Berild D, Ringertz SH, Lelek M. Appropriate antibiotic use according to diagnoses and bacteriological findings: report of 12 point-prevalence studies on antibiotic use in a university hospital. Scand J Infect Dis. 2002;34(1): 56-60. DOI: 10.1080/00365540110076912 PMID: 11874166
11. Andersen BM, Ringertz SH, Gullord TP, Hermansen W, Lelek M, Norman BI, et al. A three-year survey of nosocomial and community-acquired infections, antibiotic treatment and re-hospitalization in a Norwegian health region. J Hosp Infect. 2000;44(3): 214-23. DOI: 10.1053/jhin.1999.0677 PMID: 10706805
12. Dumpis U, Gulbinovic J, Struwe J, Lagergren A, Griskevicius L, Bergman U. Differences in antibiotic prescribing in three university hospitals in the Baltic region revealed by a simple protocol for quality assessment of therapeutic indications. Int J Clin Pharmacol Ther. 2007;45(10): 568-76. DOI: 10.5414/CPP45568 PMID: 17966843
13. Struwe J, Dumpis U, Gulbinovic J, Lagergren A, Bergman U. Healthcare associated infections in university hospitals in Latvia, Lithuania and Sweden: a simple protocol for quality assessment. Euro Surveill. 2006;11(7): 167-71. PMID: 16966795
14. Gastmeier P, Sohr D, Forster D, Schulgen G, Schumacher M, Daschner F, et al. Identifying outliers of antibiotic usage in prevalence studies on nosocomial infections. Infect Control Hosp Epidemiol. 2000;21(5): 324-8. DOI: 10.1086/501764 PMID: 10823565
15. European Centre for Disease Prevention and Control (ECDC). Annual Epidemiological Report on Communicable Diseases in Europe 2008. Stockholm: ECDC; 2008. Available from: http://ecdc.europa.eu/en/publications/Publications/0812_SUR_ Annual_Epidemiological_Report_2008.pdf
16. Medical Products Agency. Antibiotikaprofylax vid kirurgi - Behandlingsrekommendation [Antibiotic surgical prophylaxis - Treatment recommendations]. Information från Läkemedelsverket. 1998;9(7). Swedish. Available from: http://www.lakemedelsverket.se/malgrupp/Halso---sjukvard/Behandlingsrekommendationerarkiv/Behandlingsrekommendation---arkivlista/Antibiotikaprofylax-vid-kirurgi/
17. SBU - Swedish Council on Health Technology Assessment. Antibiotikaprofylax vid kirurgiska ingrepp, en systematisk litteraturöversikt - [Antibiotic prophylaxis during surgical procedures, a systematic literature review]. Stockholm: 2010 Report Number 200. Swedish. Available from: http://www. sbu.se/upload/Publikationer/Content0/1/Antibiotikaprofylax_ fulltext.pdf
18. Strålin KGG, Hedlund J, Lidman C, Spindler C, Örtqvist Å, Holmberg H. Handläggning av samhällsförvärvad pneumoni hos vuxna. Evidensbaserade riktlinjer från Svenska infektionsläkarföreningen. [Swedish guidelines for the management of adult patients with community-acquired pneumonia (CAP)]. Läkartidningen. 2008;105(38): 2582-7. Swedish. Available from: http://www.lakartidningen.se/OldWebArticlePdf/1/10284/LKT0838s2582_2587.pdf
19. Medical Products Agency. Nedre urinvägsinfektion (UVI) hos kvinnor - Behandlingsrekommendation [Lower Urinary Tract Infection (UTI) in women - Treatment recommendations]. Information från Läkemedelsverket.2007;18(2): 8-45. Swedish. Available from: http://www.lakemedelsverket. se/malgrupp/Halso---sjukvard/Behandlings--rekommendationer/Behandlingsrekommendation---listan/UVI---Nedre-urinvagsinfektion-hos-kvinnor/
20. Public Health Agency of Sweden. ESBL-producerande tarmbakterier [Extended-spectrum beta-lactamaseproducing Enterobacteriaceae]. Stockholm: 2014. Swedish. Available from: http://www. folkhalsomyndigheten.se/publicerat-material/publikationer/ESBL-producerande-tarmbakterier/
21. Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4(4): CD003543.PMID: 23633313
22. Palmcrantz S, Tistad M, Eldh AC, Holmqvist LW, Ehrenberg A, Tomson G, et al. Assessing feasibility and acceptability of study procedures: getting ready for implementation of national stroke guidelines in out-patient health care. BMC Health Serv Res. 2015;15(1): 517.DOI: 10.1186/s12913-015-1177-5 PMID: 26596624
23. Rycroft-Malone J, Seers K, Chandler J, Hawkes CA, Crichton N, Allen C, et al. The role of evidence, context, and facilitation in an implementation trial: implications for the development of the PARIHS framework. Implement Sci. 2013;8(1): 28. DOI: 10.1186/1748-5908-8-28 PMID: 23497438
24. Willemsen I, Groenhuijzen A, Bogaers D, Stuurman A, van Keulen P, Kluytmans J. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother. 2007;51(3): 864-7. DOI: 10.1128/AAC.00994-06 PMID: 17210766
25. Dimiņa E, Kūla M, Caune U, Vīgante D, Liepiņs M, Zeidaka L, et al. Repeated prevalence studies on antibiotic use in Latvia, 2003-2007. Euro Surveill. 2009;14(33): 19307. PMID: 19712639
26. Amadeo B, Zarb P, Muller A, Drapier N, Vankerckhoven V, Rogues AM, et al., ESAC III Hospital Care Subproject Group. European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. J Antimicrob Chemother. 2010;65(10): 2247-52. DOI: 10.1093/jac/dkq309 PMID: 20713405
27. Laing RB, Mackenzie AR, Shaw H, Gould IM, Douglas JG. The effect of intravenous-to-oral switch guidelines on the use of parenteral antimicrobials in medical wards. J Antimicrob Chemother. 1998;42(1): 107-11. DOI: 10.1093/jac/42.1.107 PMID: 9700538
28. Mertz D, Koller M, Haller P, Lampert ML, Plagge H, Hug B, et al. Outcomes of early switching from intravenous to oral antibiotics on medical wards. J Antimicrob Chemother. 2009;64(1): 188-99. DOI: 10.1093/jac/dkp131 PMID: 19401304
29. Sevinç F, Prins JM, Koopmans RP, Langendijk PN, Bossuyt PM, Dankert J, et al. Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital. J Antimicrob Chemother. 1999;43(4): 601-6. DOI: 10.1093/jac/43.4.601 PMID: 10350396
30. Kollef MH. Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. Clin Infect Dis. 2008;47(S1) Suppl 1;S3-13. DOI: 10.1086/590061 PMID: 18713047
31. Andersen BM, Rasch M. Hospital-acquired infections in Norwegian long-term-care institutions. A three-year survey of hospital-acquired infections and antibiotic treatment in nursing/residential homes, including 4500 residents in Oslo. J Hosp Infect. 2000;46(4): 288-96.DOI: 10.1053/jhin.2000.0840 PMID: 11170760